Protean and PersonaCRC featured by CAP Today
PersonaCRC and Protean were recently featured by CAP Today, highlighting the use of the test for patients with colorectal liver metastases.
CAP Today Link:
In select patients, taking aim at metastatic CRC - CAP TODAY
Article Recap: The CAP Today feature describes the clinical foundation and intended use of PersonaCRC (PersonaDX) in helping inform treatment planning for patients with colorectal liver metastases. It also mentions Protean BioDiagnostics as part of the testing workflow, receiving sequencing data from Caris before it is made available to PersonaDx for analysis.
For further information, please contact:
Anthony Magliocco MD
CEO & President of Protean BioDiagnostics
Email: info@proteanbiodx.com
Phone: 1 (813) 817 2042
About Protean BioDiagnostics
Protean BioDiagnostics is revolutionizing modern healthcare with our Protean MAPS™ system, which integrates health screening, diagnostics, treatment guidance, and tele-medicine backed decision support.
We collaborate with physicians and health groups to support them in providing the best possible care for their patients, regardless of where they live.